Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis

Vascular endothelial growth factor (VEGF) and its receptors are considered the primary cause of tumor-induced angiogenesis. Specifically, VEGFR-2/kinase insert domain receptor (KDR) is part of the major signaling pathway that plays a significant role in tumor angiogenesis, which is associated with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong Geon, Jin, Younggeon, Jin, Juyoun, Yang, Heekyoung, Joo, Kyeung Min, Lee, Weon Sup, Shim, Sang Ryeol, Kim, Sung-Woo, Yoo, Jinsang, Lee, Sang Hoon, Yoo, Jin-San, Nam, Do-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966428/
https://www.ncbi.nlm.nih.gov/pubmed/26325365
http://dx.doi.org/10.1080/19420862.2015.1086854

Ejemplares similares

Ejemplares similares